Bull has also held university faculty and private sector responsibilities, and has authored approximately 85 publications in diverse fields and technical journals, and presented about 103 papers at international, national, and other meetings. Professional recognition and honors include a Senior Fulbright-Hays Professorship in Grenoble, France, the Faculty-Alumni Award from the University of Missouri-Columbia, and the Secretary of Energy Outstanding Program Manager Award. Bull has a Ph.D. from Stanford University and has degrees in Chemical Engineering and Mechanical Engineering.
Douglas C. Cameron leads molecular biology and metabolic engineering R&D in the Cargill Biotechnology Development Center (BioTDC). From 1986–1998, Cameron was a professor in the Department of Chemical Engineering and an affiliate in the Molecular Biology Program at the University of Wisconsin—Madison. From 1979–1981 Cameron held the position of Biochemical Engineer at Advanced Harvesting Systems, a plant biotechnology company funded by International Harvester. Cameron is a Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and of the Society for Industrial Microbiology (SIM). He is on the editorial board of Metabolic Engineering. Cameron served on the Minnesota Governor’s Bioscience Council and is on the board of directors of MNBIO. He is a member of the MIT Biological Engineering visiting committee and is on the managing board of the Society for Biological Engineering (SBE). Cameron has a B.S.E. in biomedical engineering in 1979 from Duke University, Durham, North Carolina and a Ph.D. in biochemical engineering in 1986 from MIT, Cambridge, Massachusetts.
Berkeley W. Cue, also known as Buzz, consults with several technology companies who serve the pharmaceutical industry to create innovative solutions for pharmaceutical science and manufacturing challenges. Most recently, at Pfizer Cue was responsible for the departments (Analytical R&D, Bio Process R&D, Chemical R&D, Pharmaceutical R&D, Regulatory CMC & Quality Assurance and Pharmaceutical Sciences Business Operations) that comprise Pharmaceutical Sciences at their Groton R&D site. He created and led Pfizer’s Green Chemistry initiative and has spoken extensively on this topic since 2000. Cue retired from Pfizer in April 2004 after almost 29 years, but he continues his mission of advancing green chemistry in the pharmaceutical industry. In 2004, he gave more than a dozen presentations on green chemistry in the pharmaceutical industry. Cue received a B.A. with honors from the University of Massachusetts-Boston (1969), his Ph.D. (Organic Chemistry) from the University of Alabama (1974), and completed Postdoctoral Research at the Ohio State University (1974), National Cancer Institute Research Fellow, University of Minnesota (1975).